Riding a wave of rising investor confidence in the broader economy, shares of Franklin’s BioMimetic Therapeutics (Ticker: BMTI) have soared throughout the day.
The stock has climbed more than 13 percent today on heavy volume. As of 12:33 p.m. CST, shares were changing hands for $14.39, up $1.72 on the day. An article from MarketWatch attributes the jump seen across the biotech sector to increased investor confidence following favorable home sales figures.
Earlier this month, the company reported a net loss of close to $7 million for the fourth quarter, but said that revenue more than doubled and cash flows should improve this year.
BioMimetic Therapeutics Inc. |
Biotechnology |
Market-movers
You must be logged in to comment. If you do not have an account, you can join our esteemed subscribers.